logo

Designing a Novel Protein Inspired Therapeutic Against Xylella

Sector: Raw Materials • Location: Germany

Source: EU Funding & Tenders Portal

Project
Ongoing

This project aims to develop an innovative protein therapy to combat Xylella fastidiosa (Xf), a plant pathogen causing significant economic losses in high-value crops such as olive, grapevine, almond, and blueberries. Xf has particularly impacted agriculture in the Mediterranean Basin, with the widespread decline of ancient olive groves in southern Italy serving as a prominent example. Current man

Status
Under Construction
Sector
Raw Materials, Commercial, Education
Location
Germany
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Designing a Novel Protein Inspired Therapeutic Against Xylella

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Designing a Novel Protein Inspired Therapeutic Against Xylella” is an infrastructure initiative in the Raw Materials sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ongoing

Taiyo status

Under Construction

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

This project aims to develop an innovative protein therapy to combat Xylella fastidiosa (Xf), a plant pathogen causing significant economic losses in high-value crops such as olive, grapevine, almond, and blueberries. Xf has particularly impacted agriculture in the Mediterranean Basin, with the widespread decline of ancient olive groves in southern Italy serving as a prominent example. Current management strategies are ineffective, underscoring the need for novel disease control solutions - an issue central to the MultiX grant on Xf virulence and plant immunity. Our key inventive step is based on the hypothesis that the phytomicrobiome of a non-host plant contains factors that inhibit Xf. Through experiments and proteomics, we have identified a protein that demonstrates inhibitory activity against Xf. This protein shows significant promise and, with further refinement and optimization, could be developed into an effective therapy. Building on this discovery, PROTaX will design an effective therapeutic and demonstrated its potential to manage Xf infections. Furthermore, we will have gained a deeper understanding of market interests.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Raw Materials, Commercial, Education

Article published date

2026-02-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project